Jeff Yass’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,000
Closed -$246K 13362
2024
Q4
$246K Sell
18,000
-17,900
-50% -$259K ﹤0.01% 10249
2024
Q3
$600K Buy
35,900
+14,700
+69% +$215K ﹤0.01% 8025
2024
Q2
$252K Sell
21,200
-21,300
-50% -$243K ﹤0.01% 9840
2024
Q1
$510K Buy
42,500
+2,100
+5% +$31.3K ﹤0.01% 8469
2023
Q4
$681K Buy
40,400
+12,100
+43% +$171K ﹤0.01% 7907
2023
Q3
$424K Buy
28,300
+4,500
+19% +$75.9K ﹤0.01% 8614
2023
Q2
$448K Sell
23,800
-67,200
-74% -$1.07M ﹤0.01% 8565
2023
Q1
$1.63M Buy
91,000
+49,800
+121% +$832K ﹤0.01% 5597
2022
Q4
$343K Buy
+41,200
New +$307K ﹤0.01% 8773

Other funds holding SHC

Jeff Yass's SHC Position: Q2 2026 in Review

Jeff Yass increased its Sotera Health (SHC) stake by 304% in Q2 2026, buying an estimated $2.44M and bringing the position to 205,943 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #5222.

Jeff Yass first reported a position in SHC in Q1 2021 and has held it in 16 quarters since. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Jeff Yass held 205,943 shares of Sotera Health worth $3.66M as of Q2 2026.
  • Jeff Yass bought 154,978 Sotera Health shares in Q2 2026, an estimated $2.44M.
  • Sotera Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5222 holding.
  • Jeff Yass first reported a position in Sotera Health in Q1 2021 and has held it in 16 quarters since.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.